Exosome Derived From Human Umbilical Cord Mesenchymal Stem Cell Mediates MiR-181c Attenuating Burn-induced Excessive

Xiao Li1, Lingying Liu1, Jing Yang1

  • 1Department of Burn & Plastic Surgery, The First Affiliated Hospital to PLA General Hospital, Beijing 100048, China.

Ebiomedicine
|July 19, 2016
PubMed

Insights

Human umbilical cord mesenchymal stem cell (hUCMSC)-derived exosomes reduce burn inflammation. Exosomes containing miR-181c suppress the TLR4 pathway, decreasing inflammatory markers and improving healing in rats.

Area of Science:

  • Biomedical Engineering
  • Regenerative Medicine
  • Immunology

Background:

  • Mesenchymal stem cell (MSC)-derived exosomes modulate wound healing and inflammation.
  • The precise molecular mechanisms of human umbilical cord MSC (hUCMSC)-derived exosomes in burn inflammation remain unclear.

Purpose of the Study:

  • To elucidate the role of hUCMSC-derived exosomes in regulating burn-induced inflammation.
  • To investigate the specific molecular pathways and microRNAs involved.

Main Methods:

  • Burn injury model in rats and lipopolysaccharide (LPS)-stimulated macrophages.
  • Administration of hUCMSC-derived exosomes, including those overexpressing miR-181c.
  • Analysis of inflammatory cytokine levels (TNF-α, IL-1β, IL-10) and TLR4 signaling pathway activation.

Main Results:

  • Burn injury and LPS exposure significantly increased pro-inflammatory cytokines (TNF-α, IL-1β) and decreased anti-inflammatory IL-10.
  • hUCMSC-exosome administration reversed these inflammatory changes.
  • miR-181c within exosomes was identified as a key regulator, effectively suppressing the TLR4 pathway and reducing inflammation in burned rats.

Conclusions:

  • hUCMSC-derived exosomes mitigate burn-induced inflammation.
  • miR-181c plays a critical role by downregulating the TLR4 signaling pathway.
  • These findings highlight the therapeutic potential of hUCMSC-exosomes for managing burn-related inflammatory conditions.

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.9K
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.4K
Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.9K